Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
In post-bariatric surgery patients presenting with secondary hyperparathyroidism, what is the optimal approach to assess calcium supplementation adequacy?
Related Questions
Should we aim to reduce or stop thiazides in patients with thiazide-induced hypercalcemia given its similar risk profile to untreated primary hyperparathyroidism?
In asymptomatic patients with mild CKD, PTH independent hypercalcemia, and hypercalciuria—after excluding common causes such as hyperparathyroidism, vitamin D abnormalities, multiple myeloma, thyroid disease, vitamin A excess, and antacid use—what is the next best step in evaluation?
Are there certain patients with primary hyperparathyroidism for whom you would consider percutaneous ablation of a parathyroid adenoma over surgical parathyroidectomy?
How long should a patient be treated with a bisphosphonate after a course of an anabolic medication has been completed?
Which osteoporosis medication is best at improving bone density and hence fracture risk in the wrist?
Can FHH present with marked hypercalcemia (e.g., >12 mg/dL)?
Can cinacalcet be used short-term to manage hypercalcemia from tertiary hyperparathyroidism in advanced CKD while awaiting parathyroidectomy?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
How do you counsel patients on the risks and benefits of strontium supplements for osteoporosis management?
